The DOI matches its Crossref record.
Plasma renin activity and plasma prorenin assays
Abstract
Sensitivity and accuracy are essential features of an assay of plasma renin activity (PRA) because the normal concentration of PRA is only 1 pmol/L, and subnormal concentrations have diagnostic relevance. Conditions for blood collection need to be standardized but the conditions are not difficult for outpatients. For routine diagnostic purposes blood should be collected from ambulatory (ideally, untreated) patients on moderate sodium intake. To avoid irreversible cryoactivation of plasma prorenin (which is present in 10-fold greater concentrations than renin), samples should be processed at room temperature and stored completely frozen. Cryoactivation occurs when plasma is liquid at temperatures less than 6 degrees C. PRA is commonly measured with an enzyme kinetic assay in which angiotensin I (Ang I) is formed by the reaction of plasma renin with endogenous renin substrate (angiotensinogen). The Ang I so formed is measured by RIA; results are expressed as an hourly rate (micrograms/L formed per hour). This method, which is provided by most commercial kits, has the potential for unlimited sensitivity because the step for Ang I generation can be prolonged as long as necessary, so that enough Ang I forms to be measured accurately. Unfortunately, that sensitivity is not always exploited. Dilution of plasma during pH adjustment should be kept to a minimum. The Ang I generation step should last at least 3 h. The step should last 18 h for samples with PRA less than 1.0 micrograms/L per hour, to eliminate the errors inherent in the measurement and subtraction of immunoreactive Ang I in the untreated plasma (blank subtraction). These changes actually simplify PRA measurements because they eliminate the need for ice in the clinic and reduce by almost half the number of samples to be assayed by RIA. I also describe the method for measurement of plasma prorenin, which may be an important marker for patients with diabetes mellitus who subsequently develop vascular complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
de Simone, G., Devereux, R. B., Roman, M. J., Ganau, A., Saba, P. S., Alderman, M. H., & Laragh, J. H. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90390-5 · Cited by 607
Candidate‐based proteomics in the search for biomarkers of cardiovascular disease
Anderson, L. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.080473 · Cited by 378
Alderman, M. H., Madhavan, S., Cohen, H., Sealey, J. E., & Laragh, J. H. (1995) · Hypertension · doi:10.1161/01.hyp.25.6.1144 · Cited by 299
Self-citationBanfi, G., Salvagno, G. L., & Lippi, G. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.110 · Cited by 297
Schwartz, G. L., & Turner, S. T. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.041780 · Cited by 221
Metadata
- Authors
- Sealey, J. E.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-10-01
- Volume
- 37
- Issue
- 10
- Pages
- 1811-1819
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W1827617621
- Cited by
- 207
- References
- 0
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma renin activity and plasma prorenin assays. https://app.cochat.ai/papers/10.1093/clinchem/37.10.1811
- The paper
- Sealey, J. E. (1991). Plasma renin activity and plasma prorenin assays. Clinical Chemistry. https://doi.org/10.1093/clinchem/37.10.1811
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.